130 related articles for article (PubMed ID: 3615193)
1. Megakaryocytes and myelofibrosis in gray platelet syndrome.
Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
[TBL] [Abstract][Full Text] [Related]
2. [Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin].
Caen JP; Cramer EM; Rendu F; Bryckaert M; Dupuy E; Levy-Toledano S
Bull Acad Natl Med; 1991 Oct; 175(7):1145-52; discussion 1152-3. PubMed ID: 1809489
[TBL] [Abstract][Full Text] [Related]
3. The gray platelet syndrome: clinical spectrum of the disease.
Nurden AT; Nurden P
Blood Rev; 2007 Jan; 21(1):21-36. PubMed ID: 16442192
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
5. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors.
Breton-Gorius J; Vainchenker W; Nurden A; Levy-Toledano S; Caen J
Am J Pathol; 1981 Jan; 102(1):10-9. PubMed ID: 7468753
[TBL] [Abstract][Full Text] [Related]
6. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic changes in the megakaryocyte-platelet lineage.
Stenberg PE
Scanning Microsc; 1988 Dec; 2(4):2117-27. PubMed ID: 3238385
[TBL] [Abstract][Full Text] [Related]
8. [Beta-thromboglobulin and platelet factor 4 in a follow-up of acute myelofibrosis (megakaryoblastic leukemia)].
Palomera Bernal L; García Díez I
Med Clin (Barc); 1990 Jun; 95(1):21-4. PubMed ID: 2146451
[TBL] [Abstract][Full Text] [Related]
9. Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.
Gebrane-Younès J; Cramer EM; Orcel L; Caen JP
J Clin Invest; 1993 Dec; 92(6):3023-8. PubMed ID: 7504696
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
11. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC
Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183
[TBL] [Abstract][Full Text] [Related]
12. Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function.
Levy-Toledano S; Caen JP; Breton-Gorius J; Rendu F; Cywiner-Golenzer C; Dupuy E; Legrand Y; Maclouf J
J Lab Clin Med; 1981 Dec; 98(6):831-48. PubMed ID: 6458643
[TBL] [Abstract][Full Text] [Related]
13. [Gray platelet syndrome].
Lutz P; Roth-Pougheon A; Wiesel ML; Albert A; Brisson C; Grunebaum L; Cazenave JP; Lévy JM
Arch Fr Pediatr; 1992; 49(7):637-40. PubMed ID: 1476482
[TBL] [Abstract][Full Text] [Related]
14. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
Castro-Malaspina H
Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
[TBL] [Abstract][Full Text] [Related]
16. [TGF-beta and platelet].
Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocytes and platelets in alpha-granule disorders.
Smith MP; Cramer EM; Savidge GF
Baillieres Clin Haematol; 1997 Feb; 10(1):125-48. PubMed ID: 9154319
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural studies of the gray platelet syndrome.
White JG
Am J Pathol; 1979 May; 95(2):445-62. PubMed ID: 453324
[TBL] [Abstract][Full Text] [Related]
19. Platelets of the Wistar Furth rat have reduced levels of alpha-granule proteins. An animal model resembling gray platelet syndrome.
Jackson CW; Hutson NK; Steward SA; Saito N; Cramer EM
J Clin Invest; 1991 Jun; 87(6):1985-91. PubMed ID: 2040691
[TBL] [Abstract][Full Text] [Related]
20. Myelofibrosis and megakaryoblastic transformation of chronic myelogenous leukemia associated with intrinsic platelet dysfunction: hematological, histological and ultrastructural findings.
Cortelazzo S; D'Emilio A; Battista R; Ricciardi O; Dini E; Visonà A; Montaguti A; Pennelli N
Haematologica; 1984; 69(6):671-81. PubMed ID: 6441743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
